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The involvement of the low-
oxygen-activated locus of 
Burkholderia cenocepacia in 
adaptation during cystic fibrosis 
infection
Louise Cullen1, Andrew O’Connor1,2, Sarah McCormack2, Rebecca A. Owens3, Giles S. Holt4, 
Cassandra Collins1, Máire Callaghan1, Sean Doyle3, Darren Smith  4, Kirsten Schaffer5, 
David A. Fitzpatrick3 & Siobhán McClean  1,2
Chronic infection with opportunistic pathogens including Burkholderia cepacia complex (Bcc) is a 
hallmark of cystic fibrosis (CF). We investigated the adaptive mechanisms facilitating chronic lung 
infection in sequential Bcc isolates from two siblings with CF (P1 and P2), one of whom also experienced 
intermittent blood-stream infections (P2). We previously showed increased lung cell attachment with 
colonisation time in both P1 and P2. WGS analysis confirmed that the isolates are closely related. 
Twelve genes showed three or more mutations, suggesting these were genes under selection. Single 
nucleotide polymorphisms (SNVs) in 45 regulatory genes were also observed. Proteomic analysis 
showed that the abundance of 149 proteins increased over 61-months in sputum isolates, and both 
time- and source-related alterations in protein abundance between the second patient’s isolates. A 
consistent time-dependent increase in abundance of 19 proteins encoded by a low-oxygen-activated 
(lxa) locus was observed in both sets of isolates. Attachment was dramatically reduced in a B. 
cenocepacia K56-2Δlxa-locus deletion mutant, further indicating that it encodes protein(s) involved 
in host-cell attachment. Time-related changes in virulence in Galleria mellonella or motility were not 
observed. We conclude that the lxa-locus, associated with anoxic persistence in vitro, plays a role in 
host-cell attachment and adaptation to chronic colonization in the hypoxic niche of the CF lung.
Chronic infection is a hallmark of cystic fibrosis (CF) related lung disease. Several opportunistic pathogens, such 
as Pseudomonas aeruginosa and Burkholderia cepacia complex (Bcc) colonise the airways of CF patients impact-
ing significantly on the quality of life and mortality of people with CF. Bcc is a group of 22 genetically distinct, 
highly antibiotic resistant bacterial species1–4 associated with a more dramatic decline than P. aeruginosa5,6. About 
20% of Bcc colonised patients experience bacteraemia and “cepacia syndrome”, characterised by a sometimes 
fatal, necrotising pneumonia7. B. cenocepacia is the most virulent Bcc species and although most frequently asso-
ciated with bacteraemia, this complication has also been linked to other Bcc species5,8–10.
Although the environmental reservoirs of Bcc infection are not fully elucidated, extensive isolation of CF 
patients has limited patient-to-patient transmission with the consequence that in recent years, many Bcc infections 
are acquired from the environment. Bcc has been isolated in a range of settings including the rhizosphere11 and 
disinfectants12 and has an impressive propensity to adapt to a range of environmental conditions. In response to 
the selection pressures of the host and antimicrobial therapies, bacterial pathogens must evolve to facilitate chronic 
colonisation13,14. Much of the research on bacterial adaptation in the CF context has focused on P. aeruginosa13–16, 
while the adaptive strategies of B. cenocepacia isolates have been examined to a lesser degree17–20. Reported 
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consequences of B. cenocepacia adaptation include increased antimicrobial resistance, loss of motility, tolerance 
of iron limitation and increased virulence to host cells over time of chronic infection. In contrast, P. aeruginosa 
and B. multivorans, which is currently the most frequently isolated Bcc species in CF patients, showed reduced 
virulence over time of infection21,22. The mechanisms by which Bcc can adapt have not been elucidated to date.
We recently showed that two series of sequential isolates from two adult male siblings with CF (referred to as 
P1 and P2) increased their ability to attach to host epithelial cells over time of colonisation23. We conducted whole 
genome sequencing on six of these isolates (3 per patient) and an in-depth proteomic analysis. We were particu-
larly interested in examining the mechanisms contributing to the increased host attachment over time. Previously, 
Sass et al.24, identified a 50-gene cluster in B. cenocepacia that was highly upregulated under low oxygen culture 
conditions (lxa-locus) and was required for persistence under anoxic conditions. This is significant as there are 
clear zones of hypoxia within the CF lung, predominantly caused by oxygen consumption by host immune cells, 
particularly polymorphonuclear leukocytes25. We now show that proteins encoded on the lxa-locus are consist-
ently upregulated across both sets of patient isolates over time, highlighting that this gene cluster is relevant in vivo 
and likely to be important for niche adaptation to the hypoxic CF lung.
Results
Overview of whole genome sequencing of sequential B. cenocepacia isolates. Initial MLST of 
the sequential isolates used in this study (Supplementary information, Table S1) determined that these B. ceno-
cepacia isolates all shared the same unique sequence type (ST867)23. Individual isolates were assembled de novo. 
Average coverage ranged from 23X(P2 late blood isolate, P2B3) to 171X(P2 sputum isolate, P2S) and the N50 
scores ranged from 104238 (P2B3) to 246069 (P1 middle isolate, P1M). Total assembly lengths were approxi-
mately 7.7–7.8 million base pairs for individual species (Supplemental Table S1). We also mapped raw sequence 
reads against the B. cenocepacia J2315 reference genome, as these sequential ST867 isolates are in the same recA 
group as J2315 based on multi-locus sequence typing (MLST) sequence type. In addition, the J2315 genome is 
complete, well annotated26, actively curated (www.burkholderia.com)27 and a widely studied Bcc strain. A mean 
of 3.08 million reads were produced per isolate of which a mean of 88.31% (87.3 to 89.1%) were mapped to the 
J2315 reference with a mean coverage of 86.45% of the reference.
Comparing the concatenated MLST gene fragments from our isolates with other strains clustering under the 
same B. cenocepacia recA subgroup to construct a MLST based neighbour-joining phylogenetic tree, confirmed 
that the ST867 isolates are closely related to recA subgroup of strains (Fig. 1A). Comparative analysis of the assem-
bled sequences using BLAST Ring Image Generator (BRIG) indicated that comparable to previously reported 
B. cenocepacia CF isolates, several genomic islands appeared to be absent among the ST867 isolates, namely 
BcenGI2, BcenGI3, BcenGI6, BcenGI9, BcenGI10, BcenGI13. Furthermore our sequences had poor coverage in 
other genomic islands, e.g. BcenG15, BcenGI7, BcenG18, BcenGI12 and BcenGI14 (Fig. 1B) as has been previ-
ously shown for other patient isolates26,28. Obvious differences, including insertions and deletions of significant 
portions of genomic material, were not apparent over time of chronic lung infection from patient 1 isolates or 
between the blood and sputum associated isolations from patient 2 based on the BRIG comparison to B. cenoce-
pacia J2315 (Fig. 1B). With respect to the B. cenocepacia J2315 reference genome 57,050 and 62,532 single nucle-
otide polymorphisms (SNVs) across our six isolates were located using Genome analysis toolkit (GATK) and 
mpileup variant callers respectively. Of these 48,263 and 55,093 were found in all six isolates. From the remaining 
non-intersecting SNVs we identified 1,132 variants that were called by both GATK and mpileup. We took a con-
servative approach and only considered the SNVs located by both variant callers as bona fide.
Examining the 1132 variants across the six isolates, 976 (88%) were within genes. In total, of the 823 SNVs 
in coding regions, 528 (64%) were non-synonymous (NS) SNVs, while 36% were synonymous, the remaining 
variants were stop loss or stop gain mutations, indels and non-coding transcript variants. Based on the confident 
identification SNVs, we constructed a phylogenetic tree (Fig. 1C) to determine the relationships among the iso-
lates. The early and middle isolates from P1 (P1E and P1M) are likely to share a common ancestor, as expected. 
In addition, the late isolate from P1 (P1L) and the third blood isolate from P2 (P2B3) have evolved into a separate 
clade, based on SNVs and putative internal node observed (Fig. 1C). From this tree it appears that P2B1 and 
P2S1 are more closely related to each other than each is to either P1E and P1M or P1L and P2B3. A full list of all 
SNVs and indels observed in these isolates relative to the B. cenocepacia J2315 is provided in the Supplementary 
Information Table S2. The average evolutionary rate was 3.50 × 10−6 SNVs/bp/year in the brothers isolates, which 
is higher than that observed in other studies, for example 5.3 × 10−7 SNV/bp/year in Canadian CF B. cenocepacia 
isolates28. The high evolutionary rate may be the result of a nonsynonymous SNV in the mismatch repair gene 
mutS shared by P1L and all P2 isolates which conferred a hypermutation phenotype. The mutation rate was 
1.1 × 10−6 SNV/bp/year in the first patient prior to acquisition of the mutS mutation. The average mutation rate 
following the acquisition of the mutS mutation increased dramatically by three-fold in the later isolates, including 
all isolates from P2 which was first identified 8 months after the P1M isolate which lacked the mutS mutation.
Genes with multiple mutations or those which are fixed in the population are considered to be under selec-
tion29. There were 75 genes which had multiple mutations indicating that these genes were under strong selection 
pressure (Supplementary Information Table S2). Among these were 50 genes in which missense or frameshift 
mutations would result in an alteration of the gene product. There were 12 genes with three or more mutations 
(Table 1) which has a zero probability of occurring by chance29. In particular, the flagellar hook length control 
protein gene fliK showed 5 independent NS mutations, three in P2B3 and two in P2B1 which were unique to 
the individual isolates. There were 15 NS mutations in the BCAL1165 gene (which encodes Type VI secretion 
system base plate protein), identified in the P2S sample. This gene seemed highly mutable with 107 NS and S 
mutations in total across the six isolates. A total of eight independent mutations were observed in the proline 
transporter protein BCAL1252, seven of which were in P1L isolate. The ornibactin synthesis genes also found 
to have several mutations. The orbI gene showed 18 independent NS mutations all in the P2S isolate, while the 
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orbJ gene showed 9 NS mutations, one of which was unique to P2S and the remainder shared by P2S and P2B3 
and therefore fixed over time in this patient’s isolates. There were nine independent NS SNVs in the capsular 
polysaccharide transport gene (BCAM0209) in both late isolates, indicating selection pressure on this gene. Five 
of the mutations would result in substitutions of serines at three positions (Ser 52, Ser 47 and Ser 22). SNVs were 
also identified in 45 genes encoding for regulatory proteins, of which eight were fixed in later isolates, including 
lysR regulatory family protein genes (BCAL0707; BCAM0056; BCAM0404), two-component regulatory systems 
genes (BCAM0714) and TetR family regulatory protein gene (BCAS0083) (Table S2). The Fis family transcrip-
tional regulator BCAM0871 showed two mutations, a NS SNV (Arg to Cys) and a frameshift at Gly 321, suggest-
ing it is also a gene under selection. Interestingly, all regulatory gene SNVs were absent from P1M (using P1E 
Figure 1. (A) Phylogenetic relationship amongst 14 B. cenocepacia isolates including our six of interest. The 
phylogeny was inferred using the Neighbor-Joining method as described in the methods. Bootstrap scores are 
shown at internal nodes. Branch lengths correspond to number of base substitutions per site. (B) Comparison 
of the genome sequences of the isolates with reference genome of B. cenocepacia strain J2315 (not drawn to 
scale) created using BRIG. (C) Phylogenetic relationship amongst our six B. cenocepacia isolates of interest. 
B. cenocepacia J2315 is included as an outgroup. The phylogeny was inferred using the Maximum Parsimony 
method as described in the methods. Bootstrap scores are shown at internal nodes. Input character data 
corresponded to all 1,132 SNVs called by both GATK and mpileup variant callers.
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Location Gene product
Mutation 
Category
Type of 
mutation Presence Effect in protein
AM747720_581699
AM747720_ 581800
AM747720_ 581817
AM747720_ 582072
AM747720_ 582104
FliK, flagellar 
hook length 
control protein 
BCAL0529
CDS 5 nonsyn SNP
P2 blood 
isolates 
only
p.Pro200Thr
p.Glu233Asp
p.Leu239Pro
p.Gly324Asp
p.Gly335Arg
AM747720_1270941
AM747720_1270992
AM747720_1271269
AM747720_1271301
AM747720_1271327
AM747720_1271523
AM747720_1271597
AM747720_1271649
AM747720_1271651
AM747720_1271655
AM747720_1271661
AM747720_1271662
AM747720_1271883
AM747720_1272037
AM747720_1272747
BCAL1165, Type 
VI secretion base 
plate
CDS 15 nonsyn SNP
P2 Sputum 
isolate only
p.Val136Ile
p.Thr153Ala
p.Val245Ala
p.Thr256Ala
p.Asp264Glu
p.Ala330Thr
p.Met354Ile
p.His372Asn
p.His372Gln
p.Thr374Ala
p.Val376Ile
p.Val376Ala
p.Thr450Ala
p.Val501Ala
p.Ser738Pro
AM747720_1361546
AM747720_1361548
AM747720_1361552
AM747720_1361554
AM747720_1361566
Putative 
proline betaine 
transporter, 
BCAL1252
CDS 5 nonsyn SNP
p.Met234Ile
p.Met234Leu
p.Ile232Met
p.Ile232Val
p.Ile228Val
AM747720_1858993
AM747720_1859407
AM747720_1859523
AM747720_1860079
AM747720_1860163
AM747720_1860568
AM747720_1860791
AM747720_1861173
AM747720_1861423
AM747720_1861426
AM747720_1861604
AM747720_1862398
AM747720_1862506
AM747720_1862562
AM747720_1862590
AM747720_1863283
AM747720_1863729
AM747720_1863879
Ornibactin 
synthesis, orbI CDS 18 nonsyn,
P2 sputum 
isolate
p.Gly1174Asp
p.Gly1312Asp
p.Val1351Phe
p.Ala1536Glu
p.Ala1564Gly
p.Ala1699Val
p.Asp1773Glu
p.Ser1901Ala
p.Ala1984Glu
p.Ala1985Glu
p.Asp2044Glu
p.Arg2309His
p.His2345Arg
p.Ala2364Thr
p.Ala2373Val
p.Ile2604Thr
p.Val2753Ile
p.Arg2803Gly
AM747720_ 1867064
AM747720_ 1866582
AM747720_1866589
AM747720_1868223
AM747720_1868665
AM747720_1869043
AM747720_1869058
AM747720_1869639
AM747720_1869880
orbJ CDS 2 FS, 7 nonsyn
P2S only
All in P2 
sputum and 
late blood
p.Leu639fs
p.Ser478fs
p.Pro480Leu
p.Thr1025Ala
p.Ala1172Val
p.Gln1298Arg
p.Leu1303Pro
p.Ala1497Thr
p.Ala1577Val
AM747720_1917231
AM747720_1917465
AM747720_1917861
AM747720_1917341
Putative universal 
stress protein 
BCAL1736
Insertion
2FS
1 nonsyn
P2B1 and 
P2B3
P1B2 only
P1L
P2B3
p.Gly80_His81insGlnProGlyAlaGly
p.Gly156fs
p.Ala289fs
p.Val113Ala
AM747720_2835980
AM747720_2835981
AM747720_2836103
Putative 
transmembrane 
component of 
ABC transporter 
BCAL2576
CDS 3 nonsyn all P2B3
p.His26Tyr
p.His26Pro
p.Leu67Phe
AM747721_246833
AM747721_246838
AM747721_246845
AM747721_246847
AM747721_246848
AM747721_246850
AM747721_246874
AM747721_246923
AM747721_246953
BCAM0209 
capsular 
polysaccharide 
transport
CDS 9 nonsyn
p.Ser52Ala
p.Val50Gly
p.Thr48Ala
p.Ser47Phe
p.Ser47Pro
p.Gln46Pro
p.Met38Thr
p.Ser22Ala
p.Thr12Ala
AM747721_391712
AM747721_392768
AM747721_392870
Hypothetical 
conserved protein 
BCAM0337
CDS 3 nonsyn
P2B3
P2B3
P2S
p.Arg66His
p.Gln418Arg
p.Tyr452Cys
AM747721_1514436
AM747721_1514440
AM747721_514440
Putative penicillin 
binding protein, 
BCAM1362
2FS, 1 
nonsyn
P1L
P2 all three 
isolates
P1L
p.Pro624fs
p.Ala623fs
p.Ala623Pro
AM747722_560968
AM747722_560969
AM747722_560969
Cytochrome C 
family protein, 
BCAS0491
2FS, 1 
nonsyn
P1L
P2B1, P2S
P1M
p.Ser96fs
p.Ser98fs
p.Ser96Pro
Continued
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as the reference), consistent with the appearance of the mutS mutation (Table S2). In order to validate the WGS 
sequencing, two genes were selected, amplified and the SNPs confirmed by Sanger sequencing. The missense var-
iant at position 205 (G > A) in P2B1, was confirmed in BCAM0292 (Supplementary Fig. S1A); the synonymous 
variant at position 222 (G > A) was confirmed in P2B1 and P2S and the missense variant at position 789 (C > T) 
in P2S (Supplementary Fig. 2B) was confirmed in BCAL1700 (Supplementary Fig. S1B).
B. cenocepacia ST867 proteome alterations over time of colonization. We previously demonstrated an increase 
in host cell attachment in both series of isolates from the two patients, which was independent of the location of 
infection23. Our primary aim was to identify global changes in bacterial protein abundance over time of coloniza-
tion that may contribute to this increased host cell attachment. A comprehensive proteomic study was performed 
on the six isolates. Two types of data were obtained: (A) differentially abundant proteins with >1.5-fold alteration 
between isolates and (B) uniquely detected proteins, i.e. proteins whose presence was significantly increased 
from, or decreased to, non-detectable levels. The total numbers of altered proteins in each comparison are listed 
in Supplementary Information Table S3.
Proteins that altered over time of colonization in P1. Given that proteins are the functional molecules in cells, 
investigating alterations in protein abundance is likely to be a more informative indicator of phenotype altera-
tions. Despite the high level of SNVs observed, there were only 149 proteins that showed a statistically significant 
(P < 0.05) increased abundance by >1.5-fold over the 61-month period of chronic lung infection examined for 
patient 1 (Supplementary Information Table S4). Differentially abundant proteins of particular interest are high-
lighted in Table 2. Consistent with the previously observed increase in attachment over time of colonization, a 
substantial number of cell surface-associated proteins were significantly increased from P1E to P1L including: 
trimeric autotransporter adhesin (TAA) (BCAM0219); fimbrial usher pilus protein (BCAL1828); WbxY, involved 
in O-antigen biosynthesis, and BCAL3149, an outer membrane lipoprotein-sorting protein. Two alkylhydroper-
oxide reductases, (AhpC and AhpD), involved in responses to oxidative stress, showed increased abundance in 
P1L relative to P1E. We have previously identified AhpC as being involved in host cell attachment30.
Of particular interest were a group of 19 proteins encoded within 50-gene cluster with significantly increased 
abundance over time of chronic infection. This cluster is designated as a low-oxygen-activated (lxa) locus 
(BCAM0275-BCAM0323) which was associated with persistence in B. cenocepacia J2315 when cultured in a 
limited oxygen environment24. These 19 proteins were substantially increased (up to 40-fold) over time of chronic 
lung infection in all comparisons in P1 (Table 2). Six universal stress proteins (USP) are encoded on this locus 
and all six USPs, together with a heat shock protein, showed increased abundance in the later isolates. A BON 
(bacterial OsmY and nodulation)-domain phospholipid-binding protein (BCAM0280) showed a 30-fold abun-
dance increase over the 61-month period examined. Reduced abundance of 151 proteins over time of infection 
from the early to late sputum isolate from P1 was observed (Supplementary Information Table 4), including type 
VI secretion system (T6SS) proteins, TssF and TssG (Table 2), associated with virulence. Seventy-nine proteins 
were detected in one P1 isolate which were absent or undetectable in the other comparators (Supplementary 
Information Table 5), including penicillin binding protein, DacB and virulence factor, ZmpA31,32 which were both 
absent in the first two isolates. In contrast, another T6SS protein was only detected in P1E.
Proteins that altered over time of colonization in P2. Consistent with P1 isolates, there was also substantial 
time-associated increased abundance of 20 lxa-encoded proteins (Table 3) in the sequential P2 isolates, including 
the same 19 identified in P1 isolates with an additional uncharacterised protein (BCAM0307). Significantly the 
BON-domain phospholipid binding protein (BCAM0280) showed dramatically increased abundance (122-fold) 
in P2B3 relative to P2B1.
These isolates had also previously shown increased attachment to lung epithelial cells over time of colonisa-
tion, despite the later isolate being a blood isolate23. Consistent with this, many time-dependent alterations in 
cell surface-related proteins were observed, including proteins involved in LPS synthesis: L-arabinose formyl-
transferase, UDP-glucuronic acid decarboxylase and a glycosyltransferase which showed reduced abundance 
over time. In contrast, WbxY, involved in O-antigen synthesis was increased 3-fold from P2B1 to P2S. Fimbrial 
usher protein and BamA were also elevated in the P2B3 blood isolate relative to P2B1. The quorum sensing (QS) 
regulatory protein CepR, was elevated in abundance in both P2S and P2B3 relative to P2B1, while the abundance 
of three proteins involved in chemotaxis and motility (CheB1, CheY and GspG) were also increased over time 
from P2B1 to P2B3.
Although only one sputum isolate was available for comparison, when P2 blood and sputum isolates were 
compared for source-dependent changes, obvious differences between cell-surface associated protein abundance 
were also observed. Mpl, involved in peptidoglycan synthesis and degradation, was strongly increased (34- to 
38-fold) in P2S relative to both blood isolates (Table 3). TAA (BCAM0219) was elevated in both blood isolates 
relative to P2S. Other cell surface-related alterations include two putative OmpA family proteins (BCAL2645 
and BCAL2958), which were higher in P2S relative to both blood isolates. Other proteins that were differentially 
Location Gene product
Mutation 
Category
Type of 
mutation Presence Effect in protein
AM747720_2426852
AM747720_2427052
AM747720_2427212
BCAL2199, 
transcriptional 
regulator protein
CDS 1FS, 2 nonsyn
P1L, P2B3
P2S
P2B1
p.Ala145fs
p.Asp78Gly
p.Pro25Ser
Table 1. Genes with three or more SNVs in the B. cenocepacia sequential isolates.
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Protein
Gene ID 
J2315a Comparison Up/Down
Fold 
change
t-test P 
value
Sequence 
coverage [%]b PIc
Mol. 
weight 
[kDa]d Functione
Putative type VI secretion 
system protein TssF L0345 E → L Down 1.54 0.024 11.45 6.51 68.84
Pathogenesis/Intracellular trafficking, 
secretion, Type VI protein secretion system 
component VasA
Putative type VI secretion 
system protein TssG L0346 E → L Down 1.75 0.049 21.74 5.70 40.29
Pathogenesis/Intracellular trafficking, 
secretion, Type VI protein secretion system 
component
Putative Fur family 
transcriptional regulator L2812
E → L Down 5.92 0.000 32.70
6.22 16.83 Iron regulation
M → L Down 4.18 0.000 35.13
Putative periplasmic solute-
binding protein L2813 E → L Down 3.17 0.004 60.18 7.11 32.45
ABC metal ion transport system, 
periplasmic component/surface adhesin
Putative cytidylyltransferase L0691 E → L Up 1.66 0.003 39.68 6.29 17.46 Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides
Ornibactin biosynthesis ABC 
transport protein orbE L1695 E → M Up 8.12 0.000 5.40 7.76 62.70 Iron assimilation/ornibactin biosynthesis
Putative fimbrial usher protein L1828 E → L Up 2.99 0.001 3.25 10.07 85.88
Cell motility and secretion/Intracellular 
trafficking and secretion/P pilus assembly 
protein, porin PapC
Alkyl hydroperoxide reductase 
AhpD ahpD L2014 E → L Up 1.59 0.003 48.39 5.93 18.77 Detoxification
Uncharacterized protein wbxY L3111 E → L Up 2.32 0.038 34.70 8.44 32.74 LPS biosynthesis/O-antigen biosynthetic process
Putative exported protein L3149
E → L Up 14.66 0.000 25.83
5.97 22.72
Cell envelope biogenesis, outer membrane/
Outer membrane lipoprotein-sorting 
proteinM → L Up 1.99 0.004 39.53
CRP family regulatory protein M0049
E → L Up 3.98 0.000 61.50
7.67 27.20
Signal transduction/cAMP binding protein, 
activator and regulator of cAMP dependent 
proteases
E → M Up 1.92 0.002 51.30
M → L Up 1.87 0.000 60.00
Putative haemagluttinin-related 
autotransporter protein M0219 E → L Up 2.01 0.028 12.61 4.57 288.73
Trimeric autotransporter/YadA-like C 
terminal
Universal stress protein M0276
E → L Up 6.01 0.001 26.99
7.82 17.02 UspA family stress proteinE → M Up 3.67 0.007 24.09
M → L Up 1.76 0.016 30.98
Uncharacterized protein M0277
E → L Up 6.32 0.001 60.30
6.89 10.26 unknown function DUF1488E → M Up 2.85 0.014 40.15
M → L Up 2.22 0.013 62.90
Putative heat shock protein M0278
E → L Up 40.47 0.000 35.69
4.78 15.81 chaperone/post translational modificationE → M Up 4.35 0.001 20.65
M → L Up 3.03 0.002 36.65
Putative phospholipid-binding 
protein M0280
E → L Up 30.48 0.000 31.94
5.98 23.52 Predicted periplasmic or secreted lipoprotein/Bon domainE → M Up 4.94 0.010 17.83
M → L Up 4.73 0.000 41.44
Putative cytochrome c M0284 M → L Up 3.60 0.003 23.40 5.63 12.04 Energy production and conversion
Uncharacterized protein M0285
E → L Up 5.97 0.000 53.71
5.93 36.09 flavin or nitro compound reductionE → M Up 3.29 0.000 56.06
M → L Up 1.85 0.014 54.43
Putative universal stress protein M0290
E → L Up 8.09 0.000 56.90
4.81 16.14 UspA family Stress proteinE → M Up 4.25 0.000 71.38
M → L Up 2.00 0.001 74.43
Putative universal stress protein M0291
E → L Up 13.43 0.000 68.93
6.26 30.52 USP stress family proteinE → M Up 5.52 0.000 54.83
M → L Up 2.42 0.000 74.15
Putative universal stress protein M0292
E → L Up 16.74 0.000 37.71
5.05 17.74 UspA family stress proteinE → M Up 6.75 0.000 22.80
M → L Up 2.49 0.002 39.20
Putative universal stress protein M0294
E → L Up 10.91 0.000 60.79
6.26 30.59 UspA family stress proteinE → M Up 4.94 0.000 57.51
M → L Up 2.49 0.000 62.39
Uncharacterized protein M0295
E → L Up 2.90 0.006 37.43
5.65 19.82 hypothetical protein
M → L Up 2.10 0.011 44.00
Continued
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abundant between blood and sputum isolates include a T6SS protein, BcsL, elevated in P2S relative to both of 
the blood isolates. Increased abundance of iron acquisition-associated proteins was also seen in P2S relative to 
blood isolates, including FUR, OrbF, OrbE and OrbG. Conversely, nematocidal protein, AidA, showed increased 
abundance in both blood isolates relative to P2S.
In total there were 125 proteins that changed from being undetectable to detectable among the three P2 iso-
lates (Supplementary Information Table S5). Both time-dependent and site of isolation-related alterations were 
apparent. QS-associated protein, BCAM0188, involved in virulence factor regulation, was only detected in the 
P2B3 isolate while the virulence factor, ZmpB33, was only detected in the P2B1 and P2S isolates (Supplementary 
Information Table S5). Transmembrane protein, TolA and T6SS protein (BCAM0043) were only detected in 
the P2S and P2B3 isolates relative to P2B1 and consequently were time-dependent alterations. In contrast, iron 
acquisition proteins (OrbA and OrbB), OmpW and penicillin-binding protein, DacB, were not detected in either 
blood isolate but were present in P2S, indicating adaptations to blood.
Confirmation of up-regulation of selected genes. In order to substantiate the alterations in protein abundance, 
we examined the expression of genes encoding two consistently elevated lxa-encoded proteins, BCAM0280 
and BCAM0276 by qPCR. Consistent with the proteomic analysis, a time-dependent increase in gene expres-
sion was observed for BCAM0280 and BCAM0276 genes from all six P1 and P2 isolates in all comparisons 
(Supplementary Information Table S6). This suggests that the observed protein adaptations were the result of 
altered gene expression over time of colonization, rather than due to altered protein processing. In addition, 
late in our study we obtained an additional isolate from P1 which was isolated 90 months after P1E (and which 
Protein
Gene ID 
J2315a Comparison Up/Down
Fold 
change
t-test P 
value
Sequence 
coverage [%]b PIc
Mol. 
weight 
[kDa]d Functione
Acetoacetyl-CoA reductase phbB M0296
E → L Up 23.17 0.000 61.90
6.50 26.32 Secondary metabolite biosynthesisE → M Up 6.46 0.000 56.36
M → L Up 2.85 0.000 69.89
Putative phosphate acetyl/
butyryl transferase M0298
E → L Up 17.20 0.000 26.79
5.79 35.26 Energy production and conversionE → M Up 6.02 0.000 29.25
M → L Up 1.97 0.001 35.65
Putative zinc-binding 
alcoholdehydrogenase M0299
E → L Up 8.64 0.000 40.98
6.13 36.93 Amino acid transport and metabolism/threonine 3- dehydrogenase activityE → M Up 3.99 0.005 40.23
M → L Up 2.47 0.001 45.41
Metallo-beta-lactamase 
superfamily protein M0300
E → L Up 23.94 0.000 64.09
6.30 50.96 TranslationE → M Up 5.85 0.000 57.24
M → L Up 3.20 0.000 74.30
Uncharacterized protein M0308
E → L Up 8.02 0.000 43.36
8.93 19.46 hypothetical proteinE → M Up 3.02 0.001 33.04
M → L Up 2.55 0.000 47.29
Phosphofructokinase M0311
E → L Up 6.55 0.000 26.03
7.58 32.33 Carbohydrate transport and metabolismE → M Up 3.26 0.002 21.39
M → L Up 2.91 0.000 41.13
Uncharacterized protein M0316 E → L Up 14.10 0.007 37.98 7.06 16.85 Unknown
Putative universal stress protein M0319
E → L Up 7.56 0.000 39.54
6.36 33.62 UspA family stress proteinE → M Up 2.96 0.002 30.50
M → L Up 1.77 0.015 50.99
Putative aldobloodstream/keto 
reductase M0356 E → L Up 7.09 0.007 21.25 5.55 37.44 oxidoreductase/aldoketo reductase
Alkyl hydroperoxide reductase 
subunit C ahpC M1217 E → L Up 1.81 0.002 45.38 5.08 20.73
Adaptations to atypical conditions/
peroxiredoxin activity
Uncharacterized protein S0292
E → L Up 2.36 0.001 87.98
4.81 19.21 Inclusion body protein PixA
E → M Up 1.74 0.011 85.88
Nematocidal protein AidA aidA S0293 E → L Up 2.00 0.031 92.50 6.09 18.87 Nematocidal Virulence
Table 2. Examples of differentially abundant proteins detected in the sequential sputum isolates over time 
of chronic infection. E = early sputum isolate (P1E), M = middle sputum isolate (P1M) and L = late sputum 
isolate (P1L). aGene ID denoted by chromosome code, each letter L, M, S is preceded by BCA, i.e. L = BCAL; 
M = BCAM; S = BCAS. b% of sequence covered by matching peptides for the identified protein in the database. 
cpI isoelectric point, the pH at which the identified protein has no net charge, as determined by expasy.org 
(http://web.expasy.org/compute_pi/). dMolecular weight as determined by Q-Exactive LC-MS and max quant 
relative quantitation using B. cenocepacia J2315 database. eprotein function as determined by searching the 
burkholderia.com database27. For full list of differentially expressed proteins see Supplementary Information 
Table S5.
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Protein
Gene ID 
J2315a Comparison Up/Down
Fold 
change t-test P value
Sequence 
coverage [%]b PIc
Mol. 
Weight 
[kDa]d Functione
Chemotaxis response regulator 
protein-glutamate methylesterase cheB1 L0134
B1 → B3 Up 2.65 0.0016 26.20
8.44 38.92 chemotaxis/Cell Motility
B1 → S Up 2.70 0.0001 26.40
Chemotaxis protein CheY cheY L0135 B1 → B3 Up 3.30 0.0035 59.80 5.82 14.24 Signal transduction/chemotaxis
Putative type VI secretion system 
protein TssD bcsL L0343
S → B3 Down 1.97 0.0336 91.00
6.70 18.42
type VI secretion system effector, 
Hcp1 family/intracellular 
trafficking, secretion, and 
vesicular transport/pathogenesis
B1 → S Up 1.71 0.0139 91.00
Putative dioxygenase orbG L1690 S → B3 Down 3.33 0.0090 30.10 4.83 37.39 Iron assimilation/ornibactin biosynthesis
Ornibactin synthetase F orbF L1693
S → B3 Down 7.94 0.0001
38.70 5.74 30.81 Iron assimilation/siderophore-iron reductaseB1 → S Up 113.40 0.0000
Ornibactin biosynthesis ABC 
transport protein orbE L1695
S → B3 Down 4.54 0.0057
17.00 7.76 62.70 Iron assimilation/ornibactin biosynthesisB1 → S Up 4.91 0.0006
Putative fimbrial usher protein L1828 B1 → B3 Up 1.69 0.0130 70.60 10.07 85.88
Cell motility and secretion/
Intracellular trafficking and 
secretion/P pilus assembly 
protein, porin PapC
L-arabinose formyltransferase L1933
S → B3 Down 1.53 0.0176 33.00
6.11 33.54
lipid A Biosynthesis and 
degradation of surface 
polysaccharides and 
lipopolysaccharides Protein 
synthesis/tRNA aminoacylation
B1 → B3 Down 2.02 0.0010 23.00
UDP-glucuronic acid 
decarboxylase L1934 B1 → B3 Down 1.56 0.0012 47.80 5.76 39.45
Biosynthesis and degradation 
of surface polysaccharides and 
lipopolysaccharides
Outer membrane protein 
assembly factor BamA bamA L2083
B1 → B3 Up 1.53 0.0294 58.20
8.42 84.99 Outer membrane protein
B1 → S Up 1.82 0.0151 11.70
Putative glycosyltransferase L2404
B1 → B3 Down 1.89 0.0006 68.10
9.47 45.10 Lipopolysaccharide biosynthesis
B1 → S Down 1.66 0.0037 26.20
Putative OmpA family 
membrane protein L2645 B1 → S Up 1.61 0.0119 35.80 9.77 21.57 OmpA/MotB family protein
UDP-N-
acetylenolpyruvoylglucosamine 
reductase
murB L2768 S → B3 Down 1.61 0.0001 27.10 6.11 37.56 Peptidoglycan biosynthesis
Putative periplasmic solute-
binding protein L2813
S → B3 Down 4.82 0.0006 63.70
7.11 32.45
ABC metal ion transport sytem, 
perilasmic component/surface 
adhesin
B1 → B3 Down 27.68 0.0000 51.60
B1 → S Down 5.25 0.0001 64.00
Putative membrane protein L2947 B1 → S Up 2.26 0.0068 11.50 5.86 43.82 Lipopolysaccharide biosynthesis
Putative ompA family protein L2958 S → B3 Up 1.54 0.0403 40.10 9.28 23.97
Cell envelope biogenesis, Outer 
membrane protein and related 
peptidoglycan-associated (lipo)
proteins
Uncharacterized protein wbxY L3111 B1 → S Up 3.06 0.0054 44.20 8.44 32.74 LPS biosynthesis/O-antigen biosynthetic process
Putative TolQ transport 
transmembrane protein tolQ L3200 B1 → S Up 2.55 0.0051 20.40 9.68 24.99
Pathogenesis/Intracellular 
trafficking and secretion/
biopolymer transport protein
Putative TolR-related protein tolR L3201 B1 → S Up 1.53 0.0392 26.80 9.34 16.01
Pathogenesis/Intracellular 
trafficking and secretion/
biopolymer transport protein
Ferric uptake regulator fur L3378
S → B3 Down 1.58 0.0000 71.80
5.96 16.23 Ferric uptake regulator
B1 → S Up 1.67 0.0000 71.80
UDP-N-acetylmuramate:L-
alanyl-gamma-D-glutamyl-
meso-diaminopimelate ligase
mpl L3416
B1 → S Down 38.26 0.0000 52.70
5.84 49.48
Cell envelope biogenesis, outer 
membrane/biosynthesis & 
degradation of murein and 
peptidoglycan
S → B3 Up 34.48 0.0000 50.50
Type II secretion system protein 
G gspG L3523
B1 → B3 Up 1.75 0.0155 49.50
7.95 16.78
Cell motility and secretion/
Intracellular trafficking and 
secretion/pathogenesisB1 → S Up 2.33 0.0040 44.70
CRP regulatory protein M0049
S → B3 Up 1.54 0.001 67.70
7.67 27.20
Signal transduction/cAMP 
binding protein, activator and 
regulator of cAMP dependent 
proteases
B1 → B3 Up 5.54 0.000 58.80
B1 → S Up 3.33 0.000 69.00
Putative haemagglutinin-related 
autotransporter protein M0219
S → B3 Up 2.97 0.0005 6.70
4.57 288.73 Trimeric autotransporter/YadA-like C terminalB1 → S Down 3.04 0.0115 7.20
Continued
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Protein
Gene ID 
J2315a Comparison Up/Down
Fold 
change t-test P value
Sequence 
coverage [%]b PIc
Mol. 
Weight 
[kDa]d Functione
Universal stress protein M0276
S → B3 Up 1.65 0.0010 58.30
7.82 17.02 UspA family stress proteinB1 → B3 Up 6.74 0.0001 41.10
B1 → S Up 3.89 0.0000 34.60
Uncharacterized protein M0277
S → B3 Up 1.61 0.0263 68.10
6.89 10.26 unknown function DUF1488B1 → B3 Up 3.46 0.0001 24.30
B1 → S Up 1.92 0.0046 68.10
Putative heat shock protein M0278
S → B3 Up 6.67 0.0000 55.60
4.78 15.81 chaperone/post translational modificationB1 → B3 Up 32.93 0.0000 31.60
B1 → S Up 4.39 0.0002 24.30
Putative phospholipid-binding 
protein M0280
S → B3 Up 19.89 0.0000 53.20
5.98 23.52 Predicted periplasmic or secreted lipoprotein/Bon-domainB1 → B3 Up 122.12 0.0000 76.10
B1 → S Up 3.70 0.0355 38.90
Putative cytochrome c M0284
S → B3 Up 2.54 0.0370 23.40
5.63 12.04 Energy production and conversionB1 → B3 Up 4.13 0.0071 19.60
Uncharacterized protein M0285
S → B3 Up 1.57 0.0052 65.40
5.93 36.09 flavin or nitro compound reductionB1 → B3 Up 3.03 0.0001 61.60
B1 → S Up 1.93 0.0003 65.70
Putative universal stress protein M0290
S → B3 Up 1.64 0.0127 62.80
4.81 16.14 UspA family Stress proteinB1 → B3 Up 4.34 0.0001 56.40
B1 → S Up 2.79 0.0005 62.80
Putative universal stress protein M0291
S → B3 Up 2.15 0.0000 76.50
6.26 30.52 USP stress family proteinB1 → B3 Up 3.87 0.0000 72.20
B1 → S Up 1.65 0.0060 66.40
Putative universal stress protein M0292
S → B3 Up 2.10 0.0009 51.50
5.05 17.74 UspA family stress proteinB1 → B3 Up 5.82 0.0000 69.50
B1 → S Up 3.56 0.0000 22.80
Putative universal stress protein M0294
S → B3 Up 1.98 0.0014 64.90
6.26 30.59 UspA family stress proteinB1 → B3 Up 3.30 0.0000 25.00
B1 → S Up 1.68 0.0003 61.60
Uncharacterized protein M0295
S → B3 Down 1.84 0.0028 52.50
5.65 19.82 hypothetical proteinB1 → B3 Up 3.93 0.0033 48.70
B1 → S Up 10.07 0.0000 52.50
Acetoacetyl-CoA reductase M0296
B1 → B3 Up 4.37 0.0000 22.80
6.50 26.32 Secondary metabolite biosynthesisB1 → S Up 1.54 0.0086 62.90
S → B3 Up 2.80 0.0003 72.60
Putative phosphate acetyl/butyryl 
transferase M0298
S → B3 Up 1.67 0.0105 42.00
5.79 35.26 Energy production and conversionB1 → B3 Up 4.62 0.0000 60.00
B1 → S Up 2.18 0.0001 42.00
Putative zinc-binding 
alcoholdehydrogenase M0299
S → B3 Up 2.29 0.0027 48.30
6.13 36.93
Aminoacid transport and 
metabolism/threonine 3- 
dehydrogenase activity
B1 → B3 Up 4.24 0.0000 37.80
B1 → S Up 1.82 0.0188 43.40
Metallo-beta-lactamase 
superfamily protein M0300
S → B3 Up 1.54 0.0053 81.40
6.30 50.96 TranslationB1 → B3 Up 8.31 0.0000 55.80
B1 → S Up 4.76 0.0000 70.40
Uncharacterized protein M0307 S → B3 Up 4.67 0.0046 20.50 5.71 23.33 Unknown/Predicted periplasmic or secreted lipoprotein
Uncharacterized protein M0308
S → B3 Up 1.76 0.0002 56.80
8.93 19.46 hypothetical proteinB1 → B3 Up 2.87 0.0000 74.60
B1 → S Up 1.53 0.0021 44.40
Phosphofructokinase M0311
S → B3 Up 1.82 0.0068 55.30
7.58 32.33 Carbohydrate transport and metabolismB1 → B3 Up 5.52 0.0000 37.70
B1 → S Up 2.66 0.0003 53.10
Uncharacterized protein M0316 B1 → B3 Up 2.26 0.0380 24.90 7.06 16.85 Unknown
Putative universal stress protein M0319
B1 → B3 Up 7.98 0.0001 23.40
6.36 33.62 UspA family stress protein
B1 → S Up 5.42 0.0001 58.20
Continued
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we designated P190) and a second sputum isolate from P2 isolated 64 months after P1E. qPCR analysis of these 
additional late isolate also confirmed the two genes BCAM0280 and BCAM0276 were up-regulated over time in 
these two late additional isolates (Supplementary Table S6).
Virulence of B. cenocepacia isolates in Galleria mellonella. In order to examine whether the alterations in pro-
teomic profile resulted in other consistent phenotypic changes across the two series of isolates, virulence was 
examined. All six ST867 isolates examined were considerably less virulent than both positive control strains in 
the G. mellonella infection model and LD50 values (CFU that resulted in 50% death of the larvae) could not be 
determined for every isolate at 48 h or 72 h. Consequently LD30 values (CFU that resulted in 30% death of the 
larvae) at 48 h were used to enable comparisons of all isolates. The LD30 values were comparable across P1 isolates 
(P = 0.084). Both blood isolates (P2B1 and P2B3) were 7- to 14-fold more virulent than P2S (Fig. 2) (P < 0.05), 
consistent with an adaptation between blood and lung in this patient.
Cytokine responses of CF epithelial cells to sequential B. cenocepacia isolates. We previously demonstrated that 
Bcc strains promote potent IL-8 and IL-6 secretion from CF epithelial cells34. The alterations in proteins associ-
ated with LPS and O-antigen biosynthesis prompted us to compare proinflammatory cytokine secretions of cystic 
fibrosis bronchial epithelial cells (CFBE41o−) in response to these sequential isolates. Despite their low virulence 
in G. mellonella, the sequential sputum isolates induced comparable levels of IL-8 compared with B. cenocepacia 
K56-2 strain (Fig. 3A) (P = 0.111). A trend for increased IL-8 chemokine induction by P1 isolates relative to time 
of colonisation (P = 0.058) was observed, consistent with the increase abundance of proteins involved in LPS 
and O-antigen biosynthesis. The blood and sputum isolates from P2 induced two- to four-fold less IL-8 than 
those induced by P1 isolates (Fig. 3A) (P = 0.001). Overall secretion of a panel of nine cytokines was low relative 
to B. cenocepacia K56-2 positive control. Comparable IL-6 secretion was observed in response to the sequential 
P1 isolates; although two- to four-fold lower than that of K56-2 (Fig. 3B). Both P2 blood isolates induced 3- to 
7-fold less IL-6 relative to P2S (P < 0.01). Despite this, P2B3 induced more IL-6 than P2B1 (P < 0.05) (Fig. 3B). 
IL-4 induction by all isolates in CF cells was low (≤2 pg/ml) but within the dynamic range (0.02 to 154 pg/ml) 
and both P2 blood isolates induced lower IL-4 than the P2S isolate (P < 0.05) (Fig. 3C), consistent with IL-6 
induction. Low levels of the anti-inflammatory cytokine, IL-10 were detected in all P2 isolates (0.24 to 0.55 pg/ml; 
limit of detection 0.03 pg/ml); while IL-10 was undetectable in response to P1 isolates (Fig. 3D). Secretion of 
the remaining six cytokines (IFN-γ, TNF-α, IL-12p70, Il-13, IL-1b and Il-2) were not significantly elevated over 
media controls in response to any of the isolates.
Susceptibility of P2 isolates to the bactericidal properties of serum. In the bloodstream bacteria come in contact 
with the bactericidal components of serum. Serum bactericidal assays showed that P2S was more susceptible to 
serum killing relative to P2B1 (6.9-fold, P < 0.01) or P2B2 (2.9-fold, P < 0.05), indicating a bacterial response 
between these environments to overcome serum killing (Fig. 4). Heat inactivated serum, allowed increased sur-
vival of P2S (P < 0.005) and P2B3 (P < 0.05), demonstrating that heat sensitive components of serum contribute 
to serum resistance.
Exopolysaccharide (EPS) production and motility in sequential isolates. Previous studies have shown differences 
in motility and EPS production in sequential isolates of P. aeruginosa, B. cenocepacia and B. multivorans22,35,36. All 
P1 isolates were non-mucoid compared to P. aeruginosa positive control, PA5080, indicating no EPS-associated 
adaptation occurred in the P1 sputum isolates over 61 months of infection. P2B1 was mucoid and both later 
isolates (P2S and P2B3) lost mucoidy, indicating an adaptation to a non-mucoid phenotype (Supplementary 
Protein
Gene ID 
J2315a Comparison Up/Down
Fold 
change t-test P value
Sequence 
coverage [%]b PIc
Mol. 
Weight 
[kDa]d Functione
N-acylhomoserine lactone 
dependent regulatory protein 
CepR
cepR M1868
B1 → B3 Up 1.66 0.0404 70.80
5.60 26.61
Signal transduction mechanisms/
Transcription/positive regulation 
of single-species biofilm 
formation/intraspecies QS/
bacterial-type flagellar swarming 
motility
B1 → S Up 1.62 0.0058 19.70
Nematocidal protein AidA aidA S0293
B1 → S Down 1.87 0.0151 91.00
6.09 18.87 Virulence
S → B3 Up 1.64 0.0108 91.00
Table 3. Examples of differentially abundant proteins detected in P2 blood and sputum isolates over time 
of chronic infection. B1 = P2 first blood isolate (P2B1), S = P2 sputum isolate (P2S) and B3 = P2 third blood 
isolate (P2B3). aGene ID denoted by chromosome code, each letter L, M, S is preceded by BCA i.e. L = BCAL; 
M = BCAM; S = BCAS. b% of sequence covered by matching peptides for the identified protein in the database. 
cpI isoelectric point, the pH at which the identified protein has no net charge, as determined by expasy.org 
(http://web.expasy.org/compute_pi/). dMolecular weight as determined by Q-Exactive LC-MS and max quant 
relative quantitation using B. cenocepacia J2315 database. eprotein function as determined by searching the 
burkholderia.com database27. For full list of differentially expressed proteins see Supplementary information 
Table S5.
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Information Fig. S2). All six ST867 isolates were non-motile for swimming, swarming and twitching compared 
to P. aeruginosa (data not shown).
Δlxa-deletion mutant shows greatly impaired host cell attachment. Overall, only two consistent phenotype 
changes correlated with time of infection in the isolates from both patients: increased abundance of lxa-encoded 
proteins and our previous data showing increased host cell attachment. This prompted us to examine whether 
these two distinct phenotypes might be related and consequently, we examined the potential role of the lxa-locus 
in host cell interactions. An K56-2Δlxa-mutant strain24 showed a 12-fold reduction in attachment to CFBE41o− 
cells relative to its parent K56-2 strain (Fig. 5A), which was confirmed by confocal microscopy (Fig. 5B,C). This 
suggests that at least one or more of the proteins encoded within the 50-gene cluster is either directly involved, or 
regulates proteins involved, in host cell attachment.
Discussion
Genetic flexibility of Bcc isolates in CF infection has been previously reported20,28. Among the SNVs identified, 
12 were also identified in a separate group of three sequential isolates28, indicating common mechanisms of 
adaptation during CF infection. These included genes encoding siderophore synthesis or receptors orbA, orbK, 
BCAL1345; transcriptional regulator genes: BCAM1722, BCAM2452, BCAS0007; antibiotic resistance genes, 
BCAM1362; BCAM216 and BCAM21685; gyrA and gspD. Although the WGS analysis did not show many SNVs 
in the LXA locus, the consistent increased abundance of LXA-encoded proteins across both sets of patient isolates 
may be associated with one or more of the many mutations in regulatory protein genes. Many of the proteins 
which were undetectable in one or more of the isolates correlated to frameshift mutations in the specific isolate 
affected Table S2), which probably resulted in disrupted protein expression, including BCAL2037, BCAL2444, 
BCAL2605, BCAM0871, BCAM0881, BCAM1395 and BCAS0081.
Despite a mutS mutation in the last P1 isolate and all P2 isolates and the abundance of SNVs in regulatory 
genes in these isolates, the phenotypes investigated appeared remarkably stable in this group of sequential isolates 
in contrast to other studies in Bcc20 and P. aeruginosa37. We have examined five phenotypes across these sequen-
tial isolates (virulence in G. mellonella, cytokine stimulation, motility, mucoidy and, previously, host cell attach-
ment) and host cell attachment was the only phenotype to consistently alter with time in both sets of isolates. 
The increased epithelial attachment of B. cenocepacia ST867 in the isolates from both siblings suggests that this 
may be a general strategy facilitating survival in the host, avoiding clearance and contributing to the challenges 
of Bcc eradication once chronic infection is established. Increased host cell attachment has also been shown in 
chronic B. multivorans isolates29 and may also explain the previously observed increased bacterial invasion among 
other sequential B. cenocepacia isolates38. We therefore performed a proteomic analysis on six selected sequen-
tial isolates in order to identify a common mechanism which may mediate the niche adaptation associated with 
increased host cell attachment.
Among the altered proteins that could potentially mediate this increased host cell interaction is the 
BON-protein (BCAM0280), which was substantially elevated with time of colonization in both individuals’ 
isolates. This phospholipid-binding protein is associated with osmotic shock protection and phospholipid- or 
host-interactions39, but has not previously been linked with host cell attachment. Studies are on-going to evaluate 
this protein and its role in pathogenesis. The 2-fold increase in TAA BCAM0219 in the sequential P1 isolates may 
contribute to the increased host cell attachment of later isolates. Two TAAs in the same cluster as BCAM0219, 
(BCAM0223 and BCAM0224) were both previously implicated in epithelial cell adhesion40,41. Increased expres-
sion of this TAA (and BCAM223) was previously shown in B. cenocepacia sequential isolates42. Other cell-surface 
alterations that may contribute to the increased adherence of the sequential P1 isolates include a protein associated 
with outer membrane biogenesis (BCAL3149). However, neither BCAM0219 nor BCAL3149 were consistently 
Figure 2. Virulence of the sequential sputum isolates from P1 and blood and sputum isolates from P2 in the G. 
mellonella infection model. Bars represent the mean LD30 values at 48 hours, determined on three independent 
occasions. Error bars represent standard error of the mean; *P < 0.05 as determined by ANOVA.
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upregulated over time of colonization in the P2 isolates, suggesting that while they may contribute to increased 
lung cell attachment, these are unlikely to be part of a common mechanism of enhanced host cell interaction over 
time of colonization. Similarly, OmpA, OmpW and putative fimbrial usher protein were increased in abundance in 
the later P2 isolates and could contribute to enhanced adhesion, but they are unlikely to be part of a general mech-
anism of increased attachment over time due to the lack of alteration in P1 isolates over time. Ideally inclusion of a 
sputum isolate prior to the first blood isolate in P2 would have been helpful, however none was available. However, 
the parallel observations in the three sequential P2 isolates support the time-related alterations observed in P1.
A consistent and unexpected finding was the time-related increase in both sets of isolates of 40% of the pro-
teins encoded by the lxa-locus which is associated with B. cenocepacia survival under oxygen limitation24. This 
gene cluster encodes six USPs in addition to proteins predicted to be involved in metabolism, electron transfer 
and regulation and probably provides B. cenocepacia with a fitness advantage under hypoxic conditions. The 
blood isolates were most likely adapted to hypoxia whilst in the lungs and this adaptation was maintained in the 
bloodstream. The fact that significantly elevated abundance of 19 proteins encoded by this lxa-locus was evident 
in sequential B. cenocepacia isolates from both individuals over time of infection indicates a concerted response 
to the host. This is supported by the fact that all six USPs encoded within this locus were increased over time 
in both sets of isolates. Interestingly, USPs are also induced under hypoxic conditions in P. aeruginosa43 under 
Figure 3. Cytokine secretion from CFBE41o- cells in response to infection with the sequential B. cenocepacia 
isolates (MOI 50:1). (A) IL-8 secretion as determined by ELISA. (B,C) Cytokine release as determined by 
electrochemiluminescence (B) IL-6; (C) IL-4; (D) IL-10. Bars represent means following three independent 
experiments performed in duplicate, error bars represent standard deviation. P value signifies a statistically 
significant difference as determined by ANOVA, *P < 0.05, **P < 0.01, *** < 0.001.
Figure 4. Serum resistance of the P2 blood and sputum isolates on three independent occasions. Bars represent 
% survival of the bacteria after treatment with 30% normal human serum (NHS) or heat inactivated normal 
human serum (hNHS). Data represents % bacterial survival (CFU) relative to initial bioburden. Error bars 
represent the standard deviation of the mean. P value signifies a statistically significant difference between the 
isolates as determined by ANOVA (*P < 0.05, **P < 0.01).
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the regulation of the oxygen-sensing regulatory protein, Anr. Sass et al.24 identified a potential oxygen-sensing 
regulator in B. cenocepacia (BCAM0049) which has 43% sequence similarity to P. aeruginosa Anr24. BCAM0049 
is a cAMP-receptor regulatory protein (CRP) which showed time-dependent increased abundance in all compar-
isons from both patients (Tables 2 and 3). Recently, its homologue in B. dolosa, FixK, was shown to be under the 
control of an oxygen-sensing two component system, FixLJ which is under positive selective pressure during CF 
chronic infection44. Although neither mutations nor alterations in abundance of FixLJ homologues (BCAL2210/
BCAL2211) have been identified in these B. cenocepacia clinical isolates, BCAM0049/fixK may play a central 
regulatory role to the oxygen response in both species. Furthermore, the M. tuberculosis dormancy regulon, 
DosR, encodes 10 USPs among its 48 genes which are also upregulated during hypoxic conditions and implicated 
in long-term survival in anoxia45. The DosR regulon comprises genes with functional or phylogenetic homol-
ogy to lxa-locus genes associated with increased protein abundance in the later isolates, such as α-crystallin 
(BCAM0278) and phosphofructokinase (BCAM0311), both of which were upregulated over time in all compar-
isons. Whether lxa-locus upregulation is common across other sequential Bcc isolates remains to be explored. It 
is likely that the increased abundance of lxa-encoded proteins during chronic infection in both individuals may 
be a competitive strategy essential for B. cenocepacia persistence in the hostile host environment. The consistent 
elevated abundance of lxa-locus encoded proteins plus other USPs co-regulated with the lxa-locus24, BCAM1495 
Figure 5. Attachment of K-562 and Δlxa mutant to CFBE41o− cells. Adhesion of wild type B. cenocepacia 
strain K56-2 and Δlxa mutant strain to CFBE41o− cells was determined by microbiological plating (A) and 
confirmed by confocal microscopy (B,C). (A) Mean CFU adhered per well to CFBE41o− cells as determined 
in three independent experiments. Error bars represent standard deviation. *Statistically significant difference 
relative to K56-2 strain as determined by unpaired t-test, p < 0.001. (B) Representative confocal images of 
bacteria labelled with a rabbit anti-Bcc antibody and detected with secondary FITC-conjugated anti-rabbit 
antibody. CFBE41o− cells were counterstained with DAPI. (C) Independent zoomed in representative images 
prepared as above and superimposed on differential interference contrast imaging. (D) Quantification of 
attachment following confocal microscopy. Data represents the number of bacteria/100 cells in 10 randomly 
selected fields for each strain. Error bars represent the standard error of the mean (SEM) from two independent 
experiments. *P = 0.0017.
www.nature.com/scientificreports/
1 4Scientific RepORTS |  (2018) 8:13386  | DOI:10.1038/s41598-018-31556-6
and BCAM1500, and the potential oxygen-sensor, BCAM0049 probably contributes to niche adaptation in the 
CF lung. Furthermore, the lxa-associated proteins are the most likely candidates contributing to the increased 
attachment observed in both sets of isolates over time of colonization.
The bloodstream of P2 was acutely infected with Bcc, and consequently, the alterations observed between 
blood and sputum isolates are likely to be acute responses to the blood environment. Several adaptations were 
consistent in both blood isolates relative to P2S, despite being present in the bloodstream intermittently, sug-
gesting that these were common responses to the bloodstream. The increases in larval virulence and serum 
resistance of P2 blood isolates relative to the sputum isolate may relate to the enhanced abundance of TAA, 
BCAM021940,41. Likewise, expression of a complete LPS molecule has been associated with B. cenocepacia sur-
vival in the presence of serum46. Reduced abundance of four proteins involved in LPS synthesis in P2 blood 
isolates over 18 months, may contribute to the reduced serum resistance of P2B3 relative to P2B1 isolate. In 
addition, the pro-inflammatory properties of lipid A would suggest that reduced abundance might benefit B. 
cenocepacia blood isolates in vivo47,48. Inflammation is a significant problem in CF, leading to tissue damage. The 
lower pro-inflammatory cytokine responses elicited by the blood isolates relative to the sputum isolate from P2, 
suggests adaptations to avoid host detection, facilitating bloodstream infection. The increase in Mpl abundance, 
in P2S relative to blood isolates, may cause substantial differences in cell surface between these isolates, which 
might partially contribute to the reduced IL-6 responses of blood isolates. Overall, there seems to be a concerted 
effort to avoid clearance from the blood, with several proteins involved.
The reduced abundance of iron acquisition proteins, including five involved in synthesis of the siderophore, 
ornibactin, in the blood isolates relative to P2S are likely due to the reduced availability of iron in the lung relative 
to blood. These findings are consistent with a recent report that OrbA, among other iron acquisition proteins, 
was upregulated when B. cenocepacia was cultured under iron-restricted conditions. The reduced abundance of 
siderophore-associated proteins in blood isolates may represent a switch towards utilisation of alternative iron 
sources in blood, including haemin and ferritin, which Bcc use very effectively49. Given that iron acquisition pro-
teins have been identified as virulence factors in Bcc49,50 lower levels of these proteins by B. cenocepacia blood iso-
lates may also benefit the organism in evading host detection in blood. Increased iron metabolism by P. aeruginosa 
in the lung epithelium has been implicated in increased production of free hydroxyl-radicals, contributing to 
pulmonary damage and host response51.
There was no significant change in virulence in the G. mellonella model observed in the isolates over time of 
infection, in contrast with P. aeruginosa15,21. Interestingly, the virulence factor, ZmpA, was not detectable in P1E 
or P1M but was detected in P1L, indicative of increased expression over time, while T6SS proteins which are also 
associated with virulence showed reduced abundance in later isolates. These and many other factors can impact 
on virulence, hence the lack of any observed alteration in virulence in G. mellonella may be a consequence of 
alterations being too subtle to be identified in this model.
It is clear that B. cenocepacia ST867 adapts over time of infection by upregulating lxa-locus-encoded pro-
teins and increasing epithelial cell attachment in vitro. These were the only consistent time-dependent alterations 
across both patients’ isolates and may provide a mechanism by which B. cenocepacia chronically persists, contrib-
uting to the challenge of Bcc eradication from CF patients. Although K56-2 is a different strain (which is regularly 
examined as it is more amenable genetic manipulation) and consequently direct extrapolation is limited, the 
dramatic impairment in attachment of the Δlxa mutant strain strongly suggests that this gene cluster is involved 
(directly or indirectly) in host cell attachment. In addition, this was an in vitro study and increased attachment to 
host epithelial cells would need to be validated in vivo. There is limited data on Bcc attachment in vivo or ex vivo. 
An in-depth study of lungs of 21 patients colonised with either P. aeruginosa, Bcc or both, clearly demonstrated 
that while P. aeruginosa was located in intraluminal mucus and not adherent to airway epithelial surfaces, B. ceno-
cepacia behaved differently and appeared to grow as single cells or small clusters in macrophages, within mucus, 
or occasionally within epithelial cells52.
Sass et al.24 also predicted that the lxa locus was also involved in metabolism, transport and electron transfer. 
Consistent with this, over 249 individual proteins that were classified as having a metabolism function showed 
altered abundance in the sequential isolates, with 52% of these showing reduced abundance. Among these pro-
teins were 72 proteins classified as being energy metabolism and/or energy conversion proteins; 51 proteins 
involved in amino acid metabolism; 21 proteins classified as being involved in carbohydrate metabolism; 30 pro-
teins involved in lipid metabolism and 10 proteins involved in fatty acid metabolism (Supplementary Information 
Table S4) and highlight a substantial alteration in Bcc metabolism over time of chronic colonisation, some of 
which may be linked to the upregulation of the lxa locus.
More studies are required to determine if activation of the lxa-locus is common among larger cohorts of Bcc 
patient isolates. Furthermore the sputum from P2 showed markedly reduced virulence in G. mellonella, increased 
inflammatory properties, and enhanced serum susceptibilities relative to the blood isolates from the same 
patient, highlighting that Bcc also shows adaptive responses to the blood environment, even in the short term. 
The mechanisms behind the phenotypic differences in bacterial isolates at a given time point can be complex, but 
understanding the key adaptations that differentiate Bcc blood and sputum isolate types should contribute to the 
prevention of potentially life threatening bloodstream infections in these patients. Overall, these adaptations are 
likely to be beneficial during infection, contributing to bacterial survival during chronic infection in CF.
Methods
B. cenocepacia sequential isolates. Sequential isolates from two adult siblings with CF with the same 
unique sequence type (ST867)23 were investigated. In order to carry out an in-depth analysis, the earliest avail-
able isolate from P1 (P1E) was compared with two randomly selected sputum isolates from that patient (P1M 
(middle) and P1L (late)) with an overall time span of 61 months. The earliest available isolate from P2 was a 
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blood isolate (P2B1) which was compared with the last available blood peripheral isolate (P2B3, 16 months later) 
together with a sputum isolate (P2S) from P2 (Supplementary Information Table S1). The blood infections were 
intermittent, so these isolates were considered to have adapted to the CF lung prior to colonising the peripheral 
blood. All isolates were routinely cultured overnight in Luria Bertani (LB) broth (Sigma-Aldrich) at 37 °C.
Ethics statement. The isolates analysed in this study were collected during routine clinical practice and as 
such this study was exempt from ethical review.
DNA isolation and sequencing. Bacterial genomic DNA was isolated using a DNeasy blood and tissue kit 
(Qiagen) as per manufacturer’s specifications for Gram negative bacteria. A DNA sequencing library of bacterial 
genomic DNA was created using an Illumina Nextera XT preparation kit adding flow cell attachment and bar 
code through transposon insertion. These libraries were sequenced using Illumina V2 2 × 250 bp chemistry on 
the Illumina MiSeq Platform.
Genome assembly and SNV analysis. Low quality sequence reads and Illumina adaptors were removed 
from raw fastq files using Trimmomatic53. De novo genome assembly of all six isolates was undertaken using 
SPAdes genome assembler v.3.5.0. Reads for all six isolates were individually aligned against B. cenocepacia J2315 
using BWA-MEM version 0.7.1054. Sorting of BAM files and duplicate removal were performed with PicardTools 
2.8.2. SNVs were called independently using the GATK toolkit55 following the best practices workflow56 and 
also SAMtools mpileup57. SNPs that were called by both SNP callers were considered bona fide. Blast ring image 
generator (BRIG) was used to generate visual genome comparisons in terms of similarity and coverage to the B. 
cenocepacia J2315 reference genome58.
Phylogenetic analyses. Phylogenetic analyses were conducted in MEGA759. The phylogenetic relation-
ships of fourteen B. cenocepacia strains/isolates, including our six isolates of interest, were generated using the 
Neighbor-Joining method60 with 100 bootstrap replicates undertaken to display branch supports61. The input 
alignment was a concatenated alignment of seven housekeeping genes (BCAL0036, BCAL0289, BCAL0421, 
BCAL0953, BCAL1003, BCAL1861 & BCAM0991). Each of these genes were individually aligned and subse-
quently concatenated to give a final superalignment of 13,827 nucleotides. We removed phylogenetically unin-
formative sites and all positions containing gaps resulting in a final input alignment of 1508 nucleotides. All 
positions containing gaps and missing data were eliminated. There were a total of 1508 positions in the final data-
set. Branches corresponding to partitions reproduced in less than 50% bootstrap replicates were collapsed. The 
evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of 
the number of base substitutions per site. Additional evolutionary analyses of the isolates of interest were inferred 
using the Maximum Parsimony (MP) method. The input character data corresponded to SNP data located in this 
analysis. The MP tree was obtained using the Subtree-Pruning-Regrafting (SPR) algorithm with search level 1 in 
which the initial trees were obtained by the random addition of sequences (10 replicates). Branch supports were 
inferred using 100 bootstrap replicates.
Proteomic analysis of sequential B. cenocepacia isolates. Bacterial proteins were isolated as previ-
ously described62 from isolates which had been cultured overnight in LB broth at 37 °C, pelleted at 2778 × g for 
15 min and pellets resuspended in 0.25% (v/v) Triton X-100, 40 mM Tris pH 7.8, containing protease inhibitor 
cocktail (Roche) and sonicated on ice. Lysates were centrifuged 10,000 x g for 15 min, methanol precipitated at 
−80 °C overnight, centrifuged at 10,000 x g at 4°C for 30 min and proteins resuspended in 2 ml 8 M urea, 50 mM 
Tris-HCl pH8. Reduction, alkylation, dialysis and tryptic digestion were performed according to published meth-
ods63. Peptides (20 µl) were dried and resuspended in 0.5% trifluoroacetic acid (20 µl), sonicated and purified on 
C18 Zip-tips (Millipore) prior to mass spectrometry on a Q-Exactive hybrid quadrupole orbitrap LC-MS/MS 
(Thermo Scientific)64. Three biological replicates and one technical replicate of each digested sample were analysed.
MS files were analysed against the B. cenocepacia J2315 protein database (Uniprot). Comparative proteome 
abundance and data analysis were performed using MaxQuant software (Version 1.3.0.5)65, with Andromeda for 
database searching and Perseus (Version 1.4.1.3) for organisation and statistical analysis66 with the following set-
tings: fixed modification- carbamidomethylation of cysteines; variable modifications- oxidation of methionines 
and acetylation of N-termini; peptide/protein false discovery rates (FDR) set at 1% based on comparison to 
a reverse database. The Label-Free Quantification (LFQ) algorithm was used to generate normalised spectral 
intensities and infer relative protein abundance. Proteins were only retained in the final analysis if detected in at 
least three replicates from at least one sample. Proteins with significant abundance changes (t-test, p < 0.05; fold 
change ≥1.5) were included in the quantitative results. Qualitative analyses were also performed to detect pro-
teins found in at least 3 replicates of a sample, but undetectable in the comparator sample. Differentially expressed 
proteins were searched in the Burkholderia database (http://burkholderia.com/) to identify potential functions27. 
Expasy software was used to compute pIs (http://web.expasy.org/compute_pi/) and subcellular locations were 
determined with Psort v3.0.2 (http://www.psort.org/psortb/index.html).
Virulence in Galleria mellonella. The virulence of the sequential isolates in Galleria mellonella larvae were 
determined as described previously67. Bacterial cultures (OD600nm0.6) were serially diluted in phosphate buffered 
saline (PBS) from 10°–10−7 and 20 µl aliquots injected into the haemocoel of 10 healthy larvae per group. Negative 
control larvae were injected with PBS (20 µl). The percentage survival was determined up to 72 h. LD30 (CFU 
required to kill 30% of larvae at 48 h) was calculated from three independent experiments.
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Cytokine secretion by CFBE41o- cells. Cytokine secretion by CFBE41o− cells was determined as previ-
ously described68, with minor modifications. IL-8 levels were determined using an OptEIA™ human IL-8 ELISA 
kit (Becton-Dickenson). A wider range of cytokines were analysed using a chemiluminescent ELISA system, 
(V-PLEXTM,MesoScale Discovery) to detect IFN-γ, TNF-α, IL-10, IL-12p70, IL-13, IL-1β, IL-2, IL-4 and IL-6 
according to the manufacturer’s instructions. Cytokines were determined in duplicate on three independent 
occasions.
Assessment of sequential isolates susceptibility to the bactericidal potential of serum. Serum 
bactericidal assays were performed as previously outlined41. Blood isolates (100 µl) were added to 30% (v/v) nor-
mal human serum (NHS) (Sigma-Aldrich) or to heat inactivated NHS (hNHS). Initial bioburden was determined 
with 1:10 dilutions of cultures in PBS. All samples were incubated at 37 °C for 1 h (30 rpm), chilled and plated onto 
LB agar in duplicate. The CFU at 48 h were expressed as % survival relative to initial bioburden. Each experiment 
was performed three independent times.
Real time PCR. B. cenocepacia cultures (OD600 0.4–0.8) were incubated with RNAprotect® (Qiagen), centri-
fuged and lysed with lysozyme (1 mg/ml) in 10 mM Tris-HCl, 1 mM EDTA (pH7.5) for 10 min. RNA was isolated 
by RNeasy procedure (Qiagen) and DNase treated with turbo DNA-free kit™ (Ambion) and converted to cDNA 
using Superscript® VILO™ cDNA synthesis kit (Invitrogen). Primers (Bio-sciences) were designed using NCBI 
primer design tool (Supplementary Information Table S7). QPCR was performed using Power SYBR® green 
master mix in 25 µl containing 250 ng cDNA, 300 nM forward and reverse primers. No-template controls were 
included on each plate and amplification performed on Applied Biosystems 7300 real-time PCR system: initial 
step 95 °C, 10 min; 40 cycles of 95 °C, 5 sec and 60 °C for 1 min69. Relative quantification (RQ) expression differ-
ences were determined using the 2−ΔΔCt method.
Bacterial attachment to human CF epithelial cells. Bacterial attachment of wild type B. cenocepacia 
strain, K56-2 or Δlxa mutant to CFBE41o− cells (5 × 104 cells) on coated chamber slides (multiplicity of infec-
tion (MOI) 50:1) was determined after 30 min incubation by lysing the cells with 0.5%(v/v) Triton X-100 for 
20 minutes, serial dilution and plating on LB agar as outlined70 on three independent occasions. Confirmation of 
attachment was performed by confocal microscopy by fixing the CFBE41o− cells in 3% paraformaldehyde and 
detection with rabbit anti-Bcc antibody in 1% BSA overnight at 4 °C.
Statistical analysis. All statistical analyses were performed using Minitab Statistical software package (v15) 
unless otherwise stated. Analysis of host cell attachment, cytokine secretion and serum resistance data were deter-
mined by one-way ANOVA. Virulence data were analysed by comparing LD30 values between the isolates at 48 h 
by one-way ANOVA. Proteomic data were analysed by Perseus (Version 1.4.1.3)66 with t-tests performed for 
pairwise comparisons of samples (p < 0.05; fold change >1.5).
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